Dr. Reddy's Laboratories Limited (RDY)
Manufactures generic and branded medicines for patients worldwide.
$11.75-0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-15.7%
The outlook
RDY is trading well below its 50- and 200-day moving averages, sitting near the lower end of its 52-week range. Analyst consensus leans toward Hold with mixed coverage, though the average price target suggests roughly 14% upside from current levels. The stock's elevated valuation and bearish technical positioning reflect cautious sentiment overall.
What’s behind the score
Analyst consensusHold — 2.6 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range9% of the way from its 52-week low to high
Price targetAvg target +14% vs current price
Analyst price target
~12-month · 5 analysts$13.45average target+14.5% vs now
Now $11.75
Low $11.48High $15.71
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$9.78B
52-wk high
$15.67
52-wk low
$11.36
50-day avg
$13.44
200-day avg
$13.74
Trailing P/E
28.6